Jennifer Jorgensen is counting down the days till the coronavirus vaccine becomes available in Canada.
“Absolutely,” the 47-year-old from the small village of Fruitvale, B.C., told Global News when asked if she would take the shot.
“Because when you have a 22-year-old daughter with type 1 diabetes and a dad with a heart condition, you’ll do whatever it takes to keep everyone safe,” she said.
Health Canada officially approved Pfizer’s coronavirus vaccine on Wednesday, with a limited rollout set to begin to priority groups next week and vaccination of the general population anticipated to start in April.
With parts of the country again under lockdown and hospitals strained with COVID-19 patients across provinces amid a second wave of the virus, news of an eagerly awaited vaccine has brought some relief and optimism, but also anxiety about the unknown.
Story continues below advertisement
In a new poll last month, conducted by Leger and the Association for Canadian Studies, nearly 70 per cent of Canadians said they plan to get inoculated against the novel coronavirus once it’s approved and available.
An Ipsos survey, carried out exclusively for Global News, also found that 61 per cent of respondents support mandatory vaccination for COVID-19.
2:24 How safe is the COVID-19 vaccine?
How safe is the COVID-19 vaccine?
Experts say one of the main motivators for people to get a vaccine is to protect themselves, their loved ones and others around them.
“I don’t want myself or any more people to get sick and die,” Sheri Dusseault, 61, of Chemainus, B.C., told Global News.
After months of lockdowns, restrictions and fatigue from the pandemic, Kerry Bowman, a bioethicist at the University of Toronto, said a major secondary reason for getting vaccinated is a return to normalcy.
Story continues below advertisement
“We’ve got to move forward as a society,” Bowman said.
“Many of us want our lives back.”
For cancer survivor Karyn Methven, it is not a matter of choice, she says. The 51-year-old from Delta, B.C., told Global News she is “going to have to” take the vaccine.
“My immune system is compromised, and if I get COVID, I’m pretty much assured not to survive,” she said.
According to the U.S. CDC, having a weakened immune system may put you at a greater risk of severe illness from COVID-19.
Paula Schuck, a 52-year-old writer from London, Ont., has Crohn’s disease, which also puts her in the high-risk category. Her 16-year-old daughter has special needs and gets bronchitis almost every year, she says.
A vaccine is the “only option for our family,” Schuck told Global News.
“We have all sacrificed a lot this year. It’s time to get the vaccine which has been approved by Health Canada.”
Vaccine hesitancy and ‘nudges’
Coronavirus vaccine doses will arrive in Canada on Monday, Procurement Minister Anita Anandconfirmed on Thursday.
Story continues below advertisement
In the initial stages, up to 249,000 doses of Pfizer’s vaccine are expected this year, according to the federal government.
Health Canada announced its approval of the vaccine after reviewing clinical trial data submitted by Pfizer and BioNTech, deeming the vaccine safe for use.
Dr. Supriya Sharma, chief medical advisor with the regulatory branch of Health Canada, assured Canadians they “absolutely should feel comfortable getting the vaccine,” following a thorough approval process.
4:37 How to talk to those hesitant about the COVID-19 vaccine
How to talk to those hesitant about the COVID-19 vaccine
However, there are still concerns among sections of the population.
Peter Hall, professor of public health at the University of Waterloo, said although the vast majority of Canadians are expected to get the vaccine, “even if 10 to 20 per cent do not get vaccinated, this is a concern.”
Story continues below advertisement
“Most vaccine hesitancy is driven by a few reasons, but one of the more prominent reasons is concerns about it having some kind of negative effect or maybe misunderstanding that it has not been tested,” he told Global News.
A lower level of trust in science or scientific literacy can also cause vaccine hesitancy, Hall added.
Abbigale, 22, from St. Albert, Alta., said she was “nervous about the fast-tracking” to get the vaccine ready within months. Yet her worries about COVID-19 trump her hesitancy surrounding its vaccine.
“But I am personally much more nervous. We don’t know enough yet about who it affects or the long-term effects.”
Bowman said to build trust with the public, it was important for the government to offer clear and concise information about the vaccine: how it works, what we know, and what we don’t know.
While there are no plans to mandate the newly approved coronavirus vaccine in Canada, the province of Ontario is looking into providing immunized Ontarians a document or card to prove it.
“Nudges” without necessarily mandating the vaccine and being coercive can be helpful, Hall said.
Story continues below advertisement
In practical terms, this would mean making immunization easy and convenient to access for people, and making information about its safety and efficacy prominent, he said.
“Also, trying to anticipate and respond to some concerns in advance can reduce hesitancy.”
TORONTO – Cineplex Inc. reported a loss in its latest quarter compared with a profit a year ago as it was hit by a fine for deceptive marketing practices imposed by the Competition Tribunal.
The movie theatre company says it lost $24.7 million or 39 cents per diluted share for the quarter ended Sept. 30 compared with a profit of $29.7 million or 40 cents per diluted share a year earlier.
The results in the most recent quarter included a $39.2-million provision related to the Competition Tribunal decision, which Cineplex is appealing.
The Competition Bureau accused the company of misleading theatregoers by not immediately presenting them with the full price of a movie ticket when they purchased seats online, a view the company has rejected.
Revenue for the quarter totalled $395.6 million, down from $414.5 million in the same quarter last year, while theatre attendance totalled 13.3 million for the quarter compared with nearly 15.7 million a year earlier.
Box office revenue per patron in the quarter climbed to $13.19 compared with $12 in the same quarter last year, while concession revenue per patron amounted to $9.85, up from $8.44 a year ago.
This report by The Canadian Press was first published Nov. 6, 2024.
TORONTO – Restaurant Brands International Inc. reported net income of US$357 million for its third quarter, down from US$364 million in the same quarter last year.
The company, which keeps its books in U.S. dollars, says its profit amounted to 79 cents US per diluted share for the quarter ended Sept. 30 compared with 79 cents US per diluted share a year earlier.
Revenue for the parent company of Tim Hortons, Burger King, Popeyes and Firehouse Subs, totalled US$2.29 billion, up from US$1.84 billion in the same quarter last year.
Consolidated comparable sales were up 0.3 per cent.
On an adjusted basis, Restaurant Brands says it earned 93 cents US per diluted share in its latest quarter, up from an adjusted profit of 90 cents US per diluted share a year earlier.
The average analyst estimate had been for a profit of 95 cents US per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.
ST. JOHN’S, N.L. – Fortis Inc. reported a third-quarter profit of $420 million, up from $394 million in the same quarter last year.
The electric and gas utility says the profit amounted to 85 cents per share for the quarter ended Sept. 30, up from 81 cents per share a year earlier.
Fortis says the increase was driven by rate base growth across its utilities, and strong earnings in Arizona largely reflecting new customer rates at Tucson Electric Power.
Revenue in the quarter totalled $2.77 billion, up from $2.72 billion in the same quarter last year.
On an adjusted basis, Fortis says it earned 85 cents per share in its latest quarter, up from an adjusted profit of 84 cents per share in the third quarter of 2023.
The average analyst estimate had been for a profit of 82 cents per share, according to LSEG Data & Analytics.
This report by The Canadian Press was first published Nov. 5, 2024.